1 Dehner LP. Cervicovaginal cytology, false-negative results and standard of practice. Am J Clin Pathol, 1993, 99: 45-47. 2 Mango LJ. Computer-assisted cervical cancer screening using neural networks. Cancer， 1994, 77: 155. 3 Mango LJ. Neuromedical systems, Inc. Acta Cytol, 1996, 40:53-59. 4 Denaro LJ, Herriman JM, Shapira O. PAPNET testing system technical update. Acta Cytol, 1997; 41:65-73. 5 Rosenthal DL, Acosta D, Peters RK. computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET testing system. Acta Cytol, 1996, 40: 120-126. 6 Kurman RJ, Malkasian GD, Sedlis A， et al. From papanicolaou to bethesda: the rationale for a new cytologic classification. Obstet Gynecol, 1991, 77:779-783. 7 Koss LG, Lin E, Schreiber K, et al. Evaluation of PAPNET cytologic screening system for quality control of cervical smears. Am J Clin Pathol, 1994, 101: 220-229. 8 Slagel DD, Zaleski S, Cohen MB. Efficacy of automated cervical cytology screening.Diagn Cytopathol, 1995, 13: 26-30. 9 Mango LJ, Herriman JM. The PAPNET cytological screening system. Acta Gytol, 1996, 40：53-59.
10 Mitchell H, Medley G. Differences between papanicolaou smears with correct and incorrect diagnoses. Cytopathology, 1995, 6: 368-375.
11 Koss LG. Reducing the error rate in papanicolaou smears: one laboratory's experience with the PAPNET system. Female Patient, 1994, 19:34-40.
12 Ashfag R, Saliger F, Solares B, et al. Evalution of the PAPET system for prescreening triage of cervicovaginal smears. Acta Cytol, 1997, 41： 1058-1064.
13 Halford JA, Wright KG, Ditchmen EJ. Quality assurance in cervical cytology screening: comparison of rapid rescreening and the PAPNET testing system. Acta Cytol, 1997, 41:79-81.
14 Dudding N. Rapid rescreening of cervical smears: an improved method of quality control. Cytopathology， 1995, 6: 95-99.
15 Sherman ME, Schiffman MH, Mango LJ, et al. Evaluation of PAPNET testing as an ancillary tool to clarify the status of the“Atypical” cervical smear. Mod Pathol, 1997， 10: 564-571.
16 Kok MR, Boon ME. Consequences of neural network technology for cervical screening. increse in diagnostic consistency and positive scores. Cancer, 1996, 78:112-117.
17 Doorneward H. Negative cervical smears before CIN3/carcinoma: reevaluation with the PAPNET testing system. Acta Cytol, 1997, 41： 74-78.
18 Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papllomavirus testing for intermediate and high-risk types as triage befor colposcopy. Am J Obstet Gynecol,1995,172:1150-1157.
19 Kaufman RH, Adam E, Icenogle J, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol, 1997, 176:87-92.
20 Shafi MI, Luesley DM, Jordan JA, et al. Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytologcal abnormalities. Br J Obstet Gynecol, 1997, 104: 590-594.
21 Fife KH, Katz BP,Rouch J, et al. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol, 1996, 174:1487-1494.
22 Ashfag R, Thomas S, Saboorian MH. Efficiency of PAPNET in detecting infectious organisms in cervicovaginal smears. Acta Cytol, 1996, 40:885-888.
8690
被折叠的 条评论
为什么被折叠?
到【灌水乐园】发言
